KALV
Kalvista Pharmaceuticals Inc
NASDAQ · Biotechnology
$14.90
+0.50 (+3.47%)
Analyst Consensus
Strong Buy
15 analysts
Price Target
Analyst Price Target
+334.6% upside
Low Target
$35.35
Average Target
$64.76
High Target
$75.74
Current Price
$14.90
Current
$14.90
$14.90
Target
$64.76
$64.76
$35.35
$64.76 avg
$75.74